We have been doing funding research lately for a few different projects that address issues relevant to the LGBTQ community and came across this directory from Funders for LGBTQ Issues.
This directory of funders enables the user to search by geographic area, funding priorities and grant types. Each funder’s profile includes the following details: contact information (including the person to contact), website URLs, funding priorities, grant types, limitations, geographic priorities, how to apply and average grant size.
Check it out; it will leave you encouraged about the opportunities that are out there.
We’re wrapping up a project for one of our global health clients that is seeking to diversify their funding sources to meet their resource mobilization goals over the next five years. It’s a challenging task in this economic climate, but we’re confident they will meet their targets.
If you find yourself with the need to do research about funding for global health research and development, we relied heavily on some of the following resources:
- Policy Cures maintains the G-Finder database with support from the Bill & Melinda Gates Foundation, enabling users to search by disease, product, sector, “funding flow,” country, year and funder. In addition to sharing practical information about potential funding sources for your organization, the ability to download information allows for trend analysis as well.
- If you’re interested in gathering information regarding the prevalence of HIV, tuberculosis or malaria, we used a couple of resources: the Kaiser Family Foundation maintains a database of global health facts that enables users to produce custom data sheets.
- If you are specifically interested in data regarding tuberculosis, as we were, the BCG World Atlas is a database that enables users to search—by country—for country policies regarding BCG use, including historical use, as well as being another source for TB prevalence stats (utilizing WHO data). For those of you who are not up on their vaccine knowledge, BCG is the existing vaccine for TB, but is only partially effective and is particularly unreliable in response to adult pulmonary TB, the form of the disease that accounts for most of the disease burden worldwide.
If you have resources you think we should use in the future, please let us know.